Categories AlphaGraphs, Earnings, Health Care

Merck (MRK) Q1 Earnings: Key quarterly numbers that you need to note down

Lowers 2020 full-year revenue & EPS guidance

Merck (NYSE: MRK) today reported first quarter financial results for the period ended March 31, 2020.

On GAAP basis, first quarter EPS was $1.26 vs. $1.12 in the first quarter of 2019. Non-GAAP EPS was $1.50, compared to $1.22 in the first quarter of 2019.

Total sales increased 11% to $12.05 billion.

Shares down nearly 2% during the pre-market hours following the earnings announcement.

Merck & Co. announces financial results for first quarter 2020

In this challenging and unprecedented time, the quality of our first-quarter performance reflects strong demand for our portfolio of innovative products, continued commercial and clinical execution and the dedication and resilience of our employees around the world. The fundamentals of our business remain strong.

Kenneth C. Frazier, Chairman and CEO

You may also like:

COVID-19 puts insurers in tricky situation; risks range from litigation to insolvency

Ravaging almost every part of the world and crippling economic activity, the coronavirus pandemic has not spared any business. When it comes to the insurance industry, the nature of impact is complex and there is no doubt the companies will struggle with their underwriting decisions once the damage is fully assessed.

Check out our analysis 

Most Popular

Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results

Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where

What to look for when United Airlines (UAL) reports its Q4 2025 earnings results

Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for

Infographic: How Constellation Brands (STZ) performed in Q3 2026

Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top